Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Thrombosis 1Squamous Cell Carcinoma of Head and Neck 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Radiation Injuries 1Protein Metabolism 1Pain 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Malnutrition 1Hemorrhage 1Glioblastoma 1Erectile Dysfunction 1Disease 1Diabetes Insipidus 1

Interventions

Radiotherapy 16Amifostine 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Paclitaxel 4Donepezil 4sargramostim 3Radiosurgery 3Low-Level Light Therapy 3Filgrastim 3Etoposide 3Carboplatin 3Surveys and Questionnaires 2Radiation 2Magnetic Resonance Spectroscopy 2Esophagectomy 2Diet Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2Bevacizumab 2olaparib 1ethanethiol 1delta 24-sterol reductase 1cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vitamin E 1Vincristine 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Radiation Injuries × Arginine × Clear all
NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed
140 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡